Novartis AGBasel, Switzerland (NYSE: NVS)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Novartis Financial Statements

Novartis Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Novartis Income Statement

  2008 2007 2006
Revenue ($ mil.) 42,584.0 38,947.0 36,749.0
Gross Profit ($ mil.) 31,145.0 27,915.0 26,450.0
Operating Income ($ mil.) 9,789.0 7,724.0 8,567.0
Total Net Income ($ mil.) 8,233.0 11,968.0 7,202.0
Diluted EPS (Net Income) 3.59 5.13 3.04
More Novartis financial information

Novartis Quarterly Statements

  Quarter Ending Jun 09 Quarter Ending Mar 09 Quarter Ending Mar 09
Revenue ($ mil.) 10,742.0 9,926.0 9,926.0
Gross Profit ($ mil.) 7,918.0 7,341.0 7,341.0
Operating Income ($ mil.) 2,579.0 2,382.0 2,382.0
Total Net Income ($ mil.) 2,044.0 1,975.0 1,975.0
Diluted EPS (Net Income) 0.89 0.86 0.86
More Novartis financial information

Novartis Stock Quote & Chart

11/06/09 16:01:54 EST • NYSE • 52.80 • Increased by +0.2200 • Increased by +0.4184 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Novartis Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 2.84 2.65 7.00
Price/Earnings Ratio 15.72 16.81 25.45
Price/Book Ratio 2.24 2.88 6.74
Price/Cash Flow Ratio 10.99 10.14 43.48
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Novartis Financial Ratios

Novartis Competitive Intelligence

Johnson & Johnson Merck Pfizer
Annual Sales ($ mil.) 63,747.0 18,502.0 48,296.0
Employees 118,700 51,000 81,800
Market Cap ($ mil.) 165,490.8 46,142.1 114,870.4

Competitive Landscape

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy